Dihydrokavain (7,8-Dihydrokawain) is a natural kavalactone compound that inhibits COX-1, COX-2, CYP2C9 (IC50 = 130.95 μM), CYP2C19 (IC50 = 10.05 μM) and CYP3A4 (IC50 = 78.59 μM). It also reduces TNFα secretion and shows analgesic and anxiolytic effects.
- Natural kavalactone compound.
- Inhibits COX-1 and COX-2.
- Inhibits CYP2C9 (IC50 = 130.95 μM), CYP2C19 (IC50 = 10.05 μM), and CYP3A4 (IC50 = 78.59 μM).
- Reduces TNFα secretion.
- Shows analgesic and anxiolytic effects.